Trial intelligence / Profile preview

Remifentanil versus fentanyl for anesthesia during ERCP

IRCT20190325043107N35Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Sep 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in pain comparing Remifentanil group with Fentanyl group (2 arms). Primary endpoint: Pain. Started Sep 2023; status: completed.

02

Drugs

remifentanilfentanyl
03

Conditions

pain

Beyond the preview

Go deeper on IRCT20190325043107N35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190325043107N35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call